We are in a race to replace dangerous and obsolete surgical drills in every OR worldwide. McGinley Accessories and Custom Solutions eliminate the common obstacles to adoption of our technologies, adding safety for patients and value for our customers and investors.
McGinley Orthopedics leverages the classic “razor -blade model” with it’s proprietary surgical bits that provide the opportunity for continued revenue and customer engagement. By maximizing customer touch points over time we plan to forge strong relationships that will speed the sales process as our product lines expand.
Download our IntelliSense Drill Technology® product guide to learn more about this groundbreaking technology.
Implanted medical devices are one of the most profitable businesses in the U.S. healthcare industry. However, innovation in the bone plate space is virtually non existent and complication rates remain unconscionably high. McGinley Orthopedics’ Lever Action Plate System® is leading innovation in the sector with a plate system that offers superior strength and eliminates the guesswork and manual adjustments required by traditional plates.
Of All Fractures Are Distal Radial Fractures
Annual Addressable Market
Learn more about investing in McGinley Orthopedics
IN MAKING AN INVESTMENT DECISION, INVESTORS MUST RELY ON THEIR OWN EXAMINATION OF THE ISSUER AND THE TERMS OF THE OFFERING, INCLUDING THE MERITS AND RISKS INVOLVED. REGULATION A OFFERINGS ARE SPECULATIVE, ILLIQUID, AND INVOLVE A HIGH DEGREE OF RISK, INCLUDING THE POSSIBLE LOSS OF YOUR ENTIRE INVESTMENT.
McGinley Orthopaedic Innovations is offering securities through the use of an Offering Statement that the Securities and Exchange Commission (‘SEC”) has qualified under Tier II of Regulation A. While the SEC staff reviews certain forms and filings for compliance with disclosure obligations, the SEC does not evaluate the merits of any offering, nor does it determine if any securities offered are “good” investments.
Rialto Markets LLC (“Rialto”) is registered with the Securities and Exchange Commission (“SEC”) as a broker-dealer, member of Financial Industry Regulatory Authority, Inc. (“FINRA”) and Securities Investor Protection Corporation (“SIPC”) and is the broker-dealer of record on this issuer direct offering.
This profile may contain forward-looking statements and information relating to, among other things, the company, its business plan and strategy, and its markets or industry. These statements reflect management’s current views regarding future events based on available information and are subject to risks and uncertainties that could cause the company’s actual results to differ materially. Investors are cautioned not to place undue reliance on these forward-looking statements as they are meant for illustrative purposes, and they do not represent guarantees of future results, levels of activity, performance, or achievements, all of which cannot be made. Moreover, although management believes that the expectations reflected in the forward-looking statements are reasonable, neither McGinley Orthopaedic Innovations nor anyone acting on its behalf can give any assurance that such expectations will prove to have been correct nor do they have a duty to update any such statements to conform them to actual results.